Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review
Por:
Guirado, M, Martin, E, Villar, A, Martin, A and Sanchez-Hernandez, A
Publicada:
1 ago 2022
Ahead of Print:
1 mar 2022
Resumen:
Introduction Due to the importance of lung cancer early treatment because of its severity and extent worldwide a systematic literature review was conducted about the impact of delays in waiting times on the disease prognosis. Materials and Methods We conducted a systematic search of observational studies (2010-2020) including adult patients diagnosed with lung cancer and reporting healthcare timelines and their clinical consequences. Results We included 38 articles containing data on waiting times and prognosis; only 31 articles linked this forecast to a specific waiting time. We identified 41 healthcare time intervals and found medians of 6-121 days from diagnosis to treatment and 4-19.5 days from primary care to specialist visit: 37.5% of the intervals indicated better prognosis with longer waiting times. Conclusions All articles emphasized that waiting times must be reduced to achieve good management and prognosis of lung cancer. Further prospective studies are needed on the relationship between waiting times and prognosis of lung cancer.
Filiaciones:
:
Hosp Gen Univ Elche, Dept Med Oncol, Elche 03203, Spain
Martin, E:
Hosp Clin San Carlos, Dept Thorac Surg, Madrid, Spain
Villar, A:
Hosp Alvaro Cunqueiro Vigo, Inst Invest Sanitaria Vigo, Dept Pneumol, Vigo, Spain
Martin, A:
Hosp Durani Reynals, Dept Radiat Oncol, Barcelona, Spain
Sanchez-Hernandez, A:
Consorcio Hosp Prov Castellon, Dept Med Oncol, Castellon de La Plana 12002, Spain
hybrid, Green Published
|